Financial services is arguably the backbone of our economy. As most industries, during these times, transformation has accelerated.

The need to adapt to the acceleration of the digital world is the strategy of this highly regulated sector of the economy.

Fintech Digital Wallets & Genomics are the next sector boom.

Progress in genomics is expected to fundamentally disrupt health service delivery models by encouraging more personalized approaches to treatment.

At the forefront of this evolution are several healthcare and biotechnology companies helping to gather genetic data, identify actionable insights and develop new therapies and medicines for genetic disorders. In this post we highlight four companies that are representative of the key segments of the genomics industry targeted by the Global X Genomics & Biotechnology ETF (GNOM), including:

Genetic sequencing – Illumina

Computational biology and genetic diagnostics – Genomic Health

Genomic HealthGene therapy – Bluebird

BioGene editing – CRSPR Therapeutics